Get the latest news, insights, and market updates on HYPR (Hyperfine, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Research Frontiers And 2 Other Promising Penny Stocks To Watch
As the U.S. stock market sees fluctuations with major indices like the S&P 500 and Nasdaq hitting new records, investors are increasingly exploring diverse investment opportunities. Penny stocks, despite their old-fashioned name, remain a relevant area for those looking to uncover potential value in smaller or newer companies. By focusing on firms with solid financials and growth potential, investors can find promising opportunities among these lesser-known stocks. Oct 10, 2025 - $HYPR
Promising Penny Stocks To Consider In September 2025
As the S&P 500 and Nasdaq Composite reach new closing highs, investors are closely monitoring upcoming inflation data that could influence Federal Reserve decisions. In this context, penny stocks—often associated with smaller or newer companies—remain a relevant investment area despite their somewhat outdated term. These stocks can offer growth opportunities at lower price points, especially when backed by strong fundamentals and financial stability. Sep 11, 2025 - $HYPR
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn., August 25, 2025--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced their schedule for upcoming investor conferences. Aug 25, 2025 - $HYPR
Hyperfine (HYPR) Upgraded to Buy: Here's Why
Hyperfine (HYPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Aug 18, 2025 - $HYPR
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock? Aug 13, 2025 - $HYPR
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced second quarter 2025 financial results and provided a business update. “In the second quarter, we executed across our key growth drivers. We received FDA clearances for our latest software, Optive AITM, and for the Aug 13, 2025 - $HYPR
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" lets us enhance your experience and provide personalized content and ads.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple